Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Diabetes Care

• Publication date

  2001-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.24.12.2149PMID 11723098
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Introduction The Aging Male

  2008cited by this paper
• Nonhypoglycemic effects of thiazolidinediones.

  2001cited by this paper
• Presence of autoantibodies to carbonic anhidrase II and lactoferrin in type 1 diabetes: proposal of the concept of autoimmune exocrinopathy and endocrinopathy of the pancreas.

  2001cited by this paper
• Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat

  2001cited by this paper
• A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes.

  2001cited by this paper
• Low total plasma homocysteine concentrations in patients with type 1 diabetes.

  2001cited by this paper
• Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women.

  2000cited by this paper
• Type 1 diabetes mellitus associated with clinical acute pancreatitis in an adult.

  2000cited by this paper
• Association of autoimmune pancreatitis and type 1 diabetes: autoimmune exocrinopathy and endocrinopathy of the pancreas.

  2000cited by this paper
• Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts Male Aging Study

  2000cited by this paper
• Total homocysteine in patients with type 1 diabetes.

  2000cited by this paper
• A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies

  2000cited by this paper
• Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy.

  2000cited by this paper
• Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.

  1999cited by this paper
• Glomerular filtration rate estimation from plasma creatinine after inhibition of tubular secretion: relevance of the creatinine assay.

  1999cited by this paper
• Plantar pressures are elevated in the neuroischemic and the neuropathic diabetic foot.

  1999influential reference
• Reliability of F-Scan In-Shoe Measurements of Plantar Pressure

  1998influential reference
• Inverse correlation between serum testosterone and leptin in men.

  1998cited by this paper
• Clinical aspects of leptin.

  1998cited by this paper
• Leptin concentrations, sex hormones, and cortisol in nondiabetic men.

  1997cited by this paper
• Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study.

  1997cited by this paper
• The Role of Dynamic Plantar Pressures in Diabetic Foot Ulcers

  1997influential reference
• Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM

  1997cited by this paper
• Contribution of androgens to the gender difference in leptin production in obese children and adolescents.

  1997cited by this paper
• Reduced Expression of the Leptin Gene (ob) by Catecholamine Through a GS Protein-Coupled Pathway in 3T3-L1 Adipocytes

  1996cited by this paper
• Genetics of insulin-dependent diabetes mellitus.

  1996cited by this paper
• The Association Between Callus Formation, High Pressures and Neuropathy in Diabetic Foot Ulceration

  1996influential reference
• Reducing Dynamic Foot Pressures in High-Risk Diabetic Subjects With Foot Ulcerations: A comparison of treatments

  1996cited by this paper
• Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens.

  1995cited by this paper
• The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.

  1995cited by this paper
• Assessment and management of foot disease in patients with diabetes.

  1994cited by this paper
• Insulin Resistance, Body Fat Distribution, and Sex Hormones in Men

  1994cited by this paper
• Androgen treatment of abdominally obese men.

  1993cited by this paper
• Long‐term Use of Intramuscular Insulin Therapy in a Type I Diabetic Patient with Subcutaneous Insulin Resistance

  1993cited by this paper
• A successful technique for the treatment of diabetic neurotrophic ulcers.

  1992influential reference
• Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study

  1992cited by this paper
• The influence of aging on plasma sex hormones in men: the Telecom Study.

  1992cited by this paper
• The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.

  1992cited by this paper
• Aetiology of Diabetic Foot Ulceration: A Role for the Microcirculation?

  1992cited by this paper
• Fingerstick glucose determination in shock

  1991cited by this paper
• Does Pan-Pancreatic Involvement Occur in IDDM?

  1988cited by this paper
• Control of diabetes through a subcutaneous peritoneal access device (SPAD) in patients with resistance to subcutaneously injected insulin.

  1987cited by this paper
• In search of the subcutaneous-insulin-resistance syndrome.

  1986cited by this paper
• Treatment of type I diabetic with subcutaneous insulin resistance by a totally implantable insulin infusion device ("Infusaid").

  1984cited by this paper
• Subcutaneous Peritoneal Access Device for Type I Diabetic Patients Nonresponsive to Subcutaneous Insulin

  1982cited by this paper
• Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.

  1981cited by this paper
• Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin.

  1981cited by this paper
• Resistance against subcutaneous insulin successfully managed with aprotinin.

  1980cited by this paper
• Insulin Resistance Caused by Massive Degradation of Subcutaneous Insulin

  1979cited by this paper
• Peripheral Vascular Disease and Diabetes

  year unknowncited by this paper

• Continuous glucose monitoring in paediatric residents with normal glucose metabolism: correlations to 24-hour duty schedule

  2025cites this paper
• Body Composition, Adipocytokine, and Metabolic Parameters in Men With Congenital Hypogonadotropic Hypogonadism

  2025cites this paper
• Incidence of Type 2 Diabetes Mellitus in Transgender Individuals Undergoing Gender Affirming Hormonal Therapy: A Systematic Review

  2024cites this paper
• Testosterone in prevention and treatment of type 2 diabetes in men: Focus on recent randomized controlled trials

  2024cites this paper
• Dynamics of Sex Hormones in Men with Diabetes Mellitus After Autologous Mesenchymal Stem Cell Transplant.

  2024cites this paper
• Cardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis

  2024cites this paper
• The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health

  2022cites this paper
• The effect of different administrations of testosterone therapy on adverse prostate events: A Bayesian network meta-analysis

  2022cites this paper
• Testosterone, Diabetes Risk, and Diabetes Prevention in Men.

  2022cites this paper
• Hypogonadism, Type-2 Diabetes Mellitus, and Bone Health: A Narrative Review

  2021cites this paper
• Is There a Link Between Hormone Use and Diabetes Incidence in Transgender People? Data from the STRONG Cohort.

  2021cites this paper
• Insulin resistance in transgender individuals correlates with android fat mass

  2021cites this paper
• Efficacy of testosterone replacement therapy for treating metabolic disturbances in late-onset hypogonadism: a systematic review and meta-analysis

  2021cites this paper
• Testosterone therapy and cardiovascular diseases.

  2021cites this paper
• The effects of testosterone on bone health in males with testosterone deficiency: a systematic review and meta-analysis

  2020cites this paper
• Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review

  2020cites this paper
• Male Age and Andropause

  2020cites this paper
• Approach to Interpreting Common Laboratory Pathology Tests in Transgender Individuals

  2020cites this paper
• Transdermal or Endogenous Testosterone in Men with Androgen Deficiency Syndrome and Type 2 Diabetes Mellitus

  2019cites this paper
• Metabolic Disorders and Male Hypogonadotropic Hypogonadism

  2019cites this paper
• The association between serum total testosterone and progression of hyperglycemia: a 15‐year prospective cohort study

  2019cites this paper
• An Amino Acids Mixture Attenuates Glycemic Impairment but not Affects Adiposity Development in Rats Fed with AGEs-containing Diet

  2018cites this paper
• The new paradigm for androgenetic alopecia and plant-based folk remedies: 5α-reductase inhibition, reversal of secondary microinflammation and improving insulin resistance.

  2018cites this paper
• Testosterone a key factor in gender related metabolic syndrome

  2018cites this paper
• Androgens and the Regulation of Adiposity and Body Fat Distribution in Humans.

  2018cites this paper
• Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies.

  2018cites this paper
• Sex‐gender‐related therapeutic approaches for cardiovascular complications associated with diabetes

  2017cites this paper
• Role of Testosterone in the Treatment of Cardiovascular Disease.

  2017cites this paper
• Hypogonadism in Male Sexual Dysfunction

  2017cites this paper
• Cross‐sectional association between testosterone, sex hormone‐binding globulin and metabolic syndrome: The Healthy Twin Study

  2017cites this paper
• IL-6, cancer and cachexia: metabolic dysfunction creates the perfect storm.

  2017cites this paper
• A study to evaluate the prevalence of hypogonadism in Indian males with Type-2 diabetes mellitus

  2017cites this paper
• The Efficacy of Testosterone Ointment on Insulin Resistance in Men withMetabolic Syndrome

  2017cites this paper
• Testosterone supplementation and body composition : results from a meta-analysis study

  2016cites this paper
• Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews.

  2016cites this paper
• Benefits and Harms of Testosterone Replacement Therapy in Hypogonadal Men: A Systematic Review and Network Meta-analysis

  2016cites this paper
• THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study.

  2016cites this paper
• Sex and Gender Differences in Body Composition, Lipid Metabolism, and Glucose Regulation

  2016cites this paper
• Short-Term Estrogen Withdrawal Increases Adiposity in Healthy Men.

  2016cites this paper
• Study the association of testosterone levels with insulin resistance in Iraqi men with Diabetes mellitus type 2

  2015cites this paper
• Diabetes mellitus link with hypogonadism in male patients with type 2 diabetes mellitus aged 40-50 years

  2015cites this paper
• Tip 2 Diyabetik Erkeklerde Klinik ve Biyokimyasal Olarak Hipogonadizmin Değerlendirilmesi

  2015cites this paper
• A comprehensive review of metabolic syndrome affecting erectile dysfunction.

  2015cites this paper
• Metabolic Syndrome, Obesity Paradox and Testosterone Level

  2015cites this paper
• Low testosterone level increases fasting blood glucose level in adult males

  2015cites this paper
• Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas

  2015cites this paper
• Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis

  2014cites this paper
• Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones

  2014cites this paper
• Evaluation of adipocytokine levels and vascular functions in young aged to middle aged men with idiopathic hypogonadotrophic hypogonadism.

  2014cites this paper
• Shift work and diabetes mellitus: a meta-analysis of observational studies

  2014cites this paper
• Charakterisierung der Glukosestoffwechsellage mittels oGTT bei Personen mit Adipositas unter Berücksichtigung der Insulinsensitivität, Insulinsekretion, des HbA1c, der Dyslipoproteinämie und der Prävalenz einer Fettleber

  2014cites this paper
• Evaluation of acylation stimulating protein (ASP) and adipokines in relationship with determinants of obesity and its consequences

  2014cites this paper
• The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis

  2014cites this paper
• Reproductive and metabolic programming by exogenous steroids

  2014cites this paper
• The effect of testosterone on factors associated with diabetes, atherosclerosis and obesity.

  2014cites this paper
• Testosterone and insulin resistance in the metabolic syndrome and T2DM in men

  2013cites this paper
• Insulin Directly Regulates Steroidogenesis via Induction of the Orphan Nuclear Receptor DAX-1 in Testicular Leydig Cells*

  2013influential citation
• 12-Month Observation of Testosterone Replacement Effectiveness in a General Population of Men

  2013cites this paper
• Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study

  2013cites this paper
• Recent progress in the use of genetics to understand links between type 2 diabetes and related metabolic traits

  2013cites this paper
• Total testosterone levels, metabolic parameters, cardiac remodeling and exercise capacity in coronary artery disease patients with different stages of glucose tolerance

  2013cites this paper
• Efficacy and safety of long‐acting intramuscular testosterone undecanoate in aging men: a randomised controlled study

  2013cites this paper
• Characterization of the male ApcMin/+ mouse as a hypogonadism model related to cancer cachexia

  2013cites this paper
• Beneficial and adverse effects of testosterone on the cardiovascular system in men.

  2013cites this paper
• Prevalence of late‐onset hypogonadism in men with type 2 diabetes mellitus

  2012cites this paper
• Prostate Cancer, Androgen Deprivation Therapy, Obesity, the Metabolic Syndrome, Type 2 Diabetes, and Cardiovascular Disease: A Review

  2012cites this paper
• Androgens for postmenopausal women’s health?

  2012cites this paper
• Impact of Genetic Polymorphisms on Insulin Resistance

  2012cites this paper
• Emerging medication for the treatment of male hypogonadism

  2012cites this paper
• Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies.

  2012cites this paper
• Acute testosterone deprivation reduces insulin sensitivity in men

  2012cites this paper
• Sex Hormones, Insulin Resistance, and Diabetes Mellitus Among Men With or at Risk for HIV Infection

  2011cites this paper
• [Hypogonadism and cardiovascular diseases in men].

  2011cites this paper
• Increased adiposity in DNA binding-dependent androgen receptor knockout male mice associated with decreased voluntary activity and not insulin resistance.

  2011cites this paper
• Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men

  2011cites this paper
• Endocrinology of the aging male.

  2011cites this paper
• Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men.

  2010cites this paper
• Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis.

  2010cites this paper
• Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus.

  2010cites this paper
• Testosterone deficiency: a risk factor for cardiovascular disease?

  2010cites this paper
• Late-onset male hypogonadism and testosterone replacement therapy in primary care.

  2010cites this paper
• Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome

  2010cites this paper
• Gender‐specific aspects of treatment of cardiovascular risk factors in primary and secondary prevention

  2010cites this paper
• Serum free testosterone and metabolic syndrome in Japanese men.

  2010cites this paper
• Adverse events associated with testosterone administration.

  2010cites this paper
• Role of testosterone and cortisol in metabolic syndrome and type 2 diabetes mellitus

  2010cites this paper
• Étude de facteurs impliqués dans la variation de marqueurs inflammatoires présents dans un contexte d'obésité abdominale et de complications métaboliques associées

  2010cites this paper
• The Intimate Link Between Erectile Dysfunction and Heart Disease

  2010cites this paper
• The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process.

  2009cites this paper
• Gender differences in insulin resistance, body composition, and energy balance.

  2009cites this paper
• Testosterone in obesity, metabolic syndrome and type 2 diabetes.

  2009cites this paper
• Testosterone deficiency, insulin resistance and the metabolic syndrome

  2009cites this paper
• Testosterone and coronary artery disease.

  2009cites this paper
• Gender differences in the cardiovascular effect of sex hormones

  2009cites this paper
• Testosterone in obesity, metabolic syndrome and type 2 diabetes.

  2009cites this paper
• Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.

  2009cites this paper
• Testosterone therapy in men

  2009cites this paper
• The prevalence of and risk factors for androgen deficiency in aging Taiwanese men.

  2009cites this paper
• Hypogonadismus und infertilität bei systemischen Erkrankungen

  2009cites this paper
• Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes

  2009cites this paper